Calcitonin: The other thyroid hormone

Thyroid

Volumn 12, Issue 9, 2002, Pages 791-798

  Inzerillo, Angela M ^a   Zaidi, Mone ^a   Huang, Christopher L H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; RALOXIFENE; VITAMIN D;

CALCIUM TRANSPORT; CLINICAL TRIAL; DRUG MECHANISM; HISTOLOGY; HUMAN; HYPERCALCEMIA; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; REVIEW; THYROID GLAND; THYROID PARAFOLLICULAR CELL; TIBIA;

ANIMALS; CALCITONIN; HUMANS; THYROID GLAND;

EID: 0036738885     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502760339352     Document Type: Review

References (108)

1. Copp DH, Cheney BA 1962 Calcitonin-A hormone from the parathyroid that lowers the calcium level of the blood. Nature 193:381-382.
2. Hirsch PF, Gauthier GF, Munson PL 1963 Thyroid hypocalcaemic principle and recurrent laryngeal nerve injury as factors affecting the response to parathyroidectomy in rats. Endocrinology 73:244-250.
3. Foster GV, MacIntyre I, Pearse AGE 1964 Calcitonin production and the mitochondrion-rich cells of the dog thyroid. Nature 203:1029-1030.
4. Neher R, Riniker B, Maier R, Byfield PG, Gudmundsson TV, MacIntyre I 1968 Human calcitonin. Nature 220:984-986.
5. MacIntyre I, Parsons JA, Robinson 1967 The effect of thyrocalcitonin on blood bone calcium equilibrium in the perfused tibiae of the cat. J. Physiol. 191:393-405.
6. Zaidi M, Moonga BS, Bevis PJR, Alam ASMT, Legon S, Wimalawansa SJ, MacIntyre I, Breimer LH 1991 Expression and function of the calcitonin gene products. In: Aurbach GD (ed) Vitamins and Hormones. Volume 46. Academic Press, New York, pp. 87-164.
7. Chambers TJ 1982 Osteoblasts release osteoclasts from calcitonin-induced quiescence. J Cell Sci 57:247-253.
8. Zaidi M, Fuller K, Bevis PJR, Gaines Das RE, Chambers TJ, MacIntyre I 1987 Calcitonin gene-related peptide inhibits osteoclastic bone resorption: A comparative study. Calcif Tissue Int. 40:149-154.
9. Woodhouse NJY, Joplin GF, MacIntyre I, Doyle FH 1972 Radiological regression in Paget's disease treated by human calcitonin. Lancet 2:992-994.
10. Kanis JA, McCloskey EV 1999 Effect of calciutonin on vertebral and other fractures. Q J Med 92:143-149.
11. Zaidi M, Moonga BS, Pazianas M, Shankar VS, Huang CL-H 1997 Genetics and cell biology of calcitonin action. In: Bittar E, Bittar N (eds) Principles of Medical Biology, Volume 10B. JAI Press, Stamford, Connecticut. pp. 601-616.
12. Lou H, Gagel RF, Berget SM 1996 An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev 10:208-219.
13. Emson PC, Zaidi M 1989 Further evidence for the origin of circulating calcitonin gene-related peptide in the rat. J Physiol 412:297-308.
14. Alevizaki M, Shiraishi A, Rasool FV, Ferrier JGM, MacIntyre I Legon S 1986 The calcitonin-like sequence of the betaCGRP gene. FEBS Lett 206:47-52.
15. Peleg S, Abruzzese RV, Cooper CW, Gagel RF 1993 Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences. Mol Endocrinol 7:999-1008.
16. Monla YT, Peleg S, Gagel RF, Monla YT 1995 Cell type-specific regulation of transcription by cyclic adenosine 3′, 5′-monophosphate-responsive elements within the calcitonin promoter. Mol Endocrinol 9:784-793.
17. Zaidi M, Brain SD, Tippins JR, DiMarzo V, Moonga BS, Chambers TJ, Morris HR, MacIntyre I 1990 Structure-activity relationship of human calcitonin gene-related peptide. Biochem. J. 269:775-780.
18. Siligardi G, Samori B, Melandri S, Visconti M, Drake AF 1994 Correlations between biological activities and conformational properties of human, salmon, eel and procrine calcitonins and elcatonin elucidated by CD spectroscopy. Eur J Biochem 221:1117-1125.
19. Kapurniotu A, Taylor JW 1995 Structural and conformational requirements for human calcitonin activity: Design, synthesis and study of lactam bridge analogs. J. Med Chem 38:836-847.
20. Breimer LH, MacIntyre I, Zaidi M 1988 Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J 255:377-390.
21. Holtrop NE, Raisz LJ, Simmons HA 1974 The effects of parathyroid hormone, colchicines and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 60:346-355.
22. Kallio DM, Ganat PR, Minkin C 1972 Ultrastructural effects of calcitonin on osteoclasts in tissue culture. J Ultrastround Res 39:205-216.
23. Chambers TJ, Magnus CJ 1982 Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136:97-106.
24. Zaidi M, Alam ASMT, Shankar VS, Bax BE, Moonga BS, Bevis PJR, Pazianas M, Huang CL-H 1992 A quantitative description of components of in vitro morphometric change in the rat osteoclast model: Relationships with cellular function. Eur Biophys J 21:349-355.
25. Zaidi M, Shankar VS, Huang CL-H, Pazianas M 1994 Molecular mechanisms of calcitonin action. Endocr J 2:459-467.
26. Yumita S, Nicholson GC, Rowe DJ, Kent GN, Martin TJ 1991 Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts. J Bone Miner Res 6:591-591.
27. Chambers TJ, Fuller K, Darby JA 1987 Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone. J Cell Physiol 132:90-96.
28. Akisaka T, Gay CV 1986 Ultracytochemical evidence for a proton pump adenosine trisphosphate in chick osteoclasts. Cell Tissue Res 245:507-512.
29. Moonga BS, Moss DW, Patchell A, Zaidi M 1990 Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J Physiol 429:29-45.
30. Chambers TJ, McSheehy PMJ, Thompson BM, Fuller K 1985 The effect of calcium regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from rabbit long bones. Endocrinology 116:234-239.
31. Dempster DW, Murills RJ, Horbert W, Arnett TR 1987 Biological activity of chicken calcitonin: effects on neonatal rat and embryonic chick osteoclasts. J Bone Miner Res 2: 443-448.
32. Zaidi M, Chambers TJ, Bevis PJR, Beacham JL, Gaines Das RE, MacIntyre I 1988 Effects of peptides from the calcitonin genes on bone and bone cells. Q J Exp Physiol 73:471-485.
33. Datta HK, Zaidi M, Wimalawansa SJ, Ghatei MA, Beacham JL, Bloom SR, MacIntyre I 1989 In vitro and in vivo effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem. Biophys Res Commun 162:876-881.
34. Yoshida N, Yoshida T, Nakamura A, Monkawa T, Hayashi M, Saruta T 1999 Calcitonin induces 25-hydroxyvitamin D3 1alpha hydroxylase mRNA expression via protein kinase C pathway in LLCPK1 cells. J Am Soc Nephrol 10:2474-2479.
35. Chakraborty M, Chatterjee D, Gorelick FS, Baron R 1994 Cell cycle dependent kinase-specific regulation of the apical Na/H exchanger and the Na, K-ATPase in the kidney cell line LLCPK1 by calcitonin. Proc Natl Acad Sci 91: 2115-2119.
36. Wallach S, Rousseau G, Martin L, Azria M 1999 Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 25:509-516.
37. Okubo Y, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, lizuka T 2000 Effect of e-calcitonin on osteoinduction by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 269:317-321.
38. Farley J, Dimai HP, Stilt-Coffing B, Farley P, Pham T, Mohan S 2000 Calcitonin increases the concentration of insulin-like growth factors in serum-free cultures of human osteoblast-like cells. Calcif Tissue Int 67:247-254.
39. Plotkin LI, Weinstein RS, Parfitt AM, Robertson PK, Manolagas SC, Bellido T 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374.
40. Evdokiou A, Raggatt LJ, Sakai T, Findlay DM 2000 Identification of a novel calcitonin response element in th epromoter of the human p21 WAF1.CIP1 gene. J Mol Endocrinol 25:195-206.
41. Mancini L, Moradi-Bidhendi N, Brandi ML, Perretti M, MacIntyre I 2000 Modulation of the effects of osteoprotegrin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. Biochem Biophys Res Commun 279:391-397.
42. Agus ZS, Wasserstein S, Goldfarb S 1981 PTH, calcitonin, cyclic nucleotides and the kidney. Ann Rev Physiol 43: 583-595.
43. 3-1-alpha-hydroxylase gene in normocalcemic rats. Proc Natl Acad Sci 96:8253-8258.
44. Goldring SR, Gorn AH, Yamin M, Krane SM, Wang JT 1993 Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs. Horm Metab Res 25:477-480.
45. Wimalawansa SJ 1996 Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology elegy and therapeutic potential. Endocr Rev 17:533-585.
46. Ho HH, Gilbert MT, Nussenzveig DR, Gershengorn MC 1999 Glycosylation is important for binding to human calcitonin receptors. Biochemistry 38:1866-1872.
47. Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, Kakuda K 1995 A new type of calcitonin receptor isoform generated by alternative splicing. Biochem Biophys Res Commun 209:744-751.
48. Moore EE, Kuestner RE, Stroop SD, Grant FJ, Matthews SL, Brady CL, Sexton PM, Findlay DM 1995 Functionally different isoforms of the human calcitonin receptor result from the alternative splicing of the gene transcript. Mol Endocrinol 9:959-968.
49. Nussenzveig DR, Matthew S, Gershengorn MC 1995 Alternative splicing of a 48-nucleotide exon generates two isoforms of the calcitonin receptor. Endocrinology 136:2047-2051.
50. Yamin M, Gorn AH, Flannery MR, Jenkins MA, Gilbert DJ, Copeland NG, Tapp DR, Krane SM, Goldring SR 1994 Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology 135:2635-2643.
51. Force T, Bonventre JV, Flannery MR, Gorn AH, Yamin M, Goldring SR 1992 A cloned porcine renal calcitonin receptor coupled to adenylyl cyclase and phospholipase C Am J Physiol 262:F1110-1115.
52. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR 1992 Cloning, characterization and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90:1726-1735.
53. Su Y, Chakarborty M, Nathanson MH, Baron R 1992 Differential effects of the 3′5′-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated osteoclasts to calcitonin. Endocrinology 12:1497-1502.
54. Nussenzveig DR, Thaw CN, Gershengorn MC 1994 Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor. J Biol Chem 269:28123-28129.
55. Houssami S, Findlay D, Brady CL, Myers DE, Martin TJ, Sexton PM 1994 isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135:183-190.
56. Ikegame M, Rakapoulos M, Zhou H, Houssami S, Martin TJ, Moseley JM, Findlay DM 1995 Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Min Res 10:59-65.
57. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FAO, Martin TJ 1986 Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78:355-360.
58. Inoue D, Shih C, Galson DL, Goldring SR, Horne WC, Baron R 1999 Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology 140:1060-1068.
59. Wada S, Akatsu T, Tamura T, Takahashi N, Suda T, Nagata N 1994 Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells. J Bone Miner Res 9:1705-1712.
60. Takahashi S, Goldring SR, Katz M, Hilsenbeck S, Williams R, Roodman GD 1995 Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167-171.
61. Samura A, Wada S, Suda S, Iitaka M, Katayama S 2000 Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor kappaB ligand and macrophage colony-stimulating fator. Endocrinology 141:3774-3782.
62. Tverberg LA, Gustafson MF, Scott TL, Arzumanova IV, Provost ER, Yan AW, Rawie SA 2000 Induction of calcitonin and calcitonin receptor expression in rat mammary tissue during pregnancy. Endocrinology 141:3696-3702.
63. Jagger C, Chambers TJ, Pondel M 2000 Transgenic mice reveal novel sites of calcitonin receptor gene expression during development. Biochem Biophys Res Commun 274: 124-129.
64. Stroop SD, Moore EE 1995 Intracellular calcium increases mediated by a recombinant human calcitonin receptor. J Bone Miner Res 10:524-532.
65. 2+ sensor. J Clin Invest 96:1582-1590.
66. Zaidi M, Shankar VS, Adebanjo OA, Lai FA, Pazianas M, Sunavala G, Spielman AI, Rifkin BR 1996 Regulation of extracellular calcium-sensing in rat osteoclasts by femtomolar calcitonin concentrations. Am J Physiol 271:F637-F644.
67. Sun L, Adebanjo OA, Moonga BS, Corsideo S, Anandathreethavarada HK, Biswas G, Toshiya A, Hakeda Y, Koval A, Sodam BR, Bevis PJR, Moser AJ, Lai FA, Epstein S, Troen BR, Kumegawa M, Zaidi M 1999 CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption. J Cell Biol 146:1161-1171.
68. 2+ homeostasis. Nat Cell Biol 7:409-414.
69. 2+ transport through IP3Rs and RyRs in osteoblasts. Am J Physiol 278:F784-F791.
70. Orcell P, Tajima H, Murayama Y, Fujita T, Krane SM, Ogata E, Goldring SR, Nishimoto I 2000 Multiple domains interacting with Gs in the porcine calcitonin receptor. Mol Endocrinol 14:170-182.
71. Shyu JF, Inoue D, Baron R, Horne WC 1996 The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C. J Biol Chem 271:31127-31134.
72. Stroop SD, Nakamuta H, Kuestner RE, Moore EE, Epand RE 1996 Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane loop regions. Endocrinology 137:4752-4756.
73. Stroop SD, Kuestner RE, Serwold TF, Chen L, Moore EE 1995 Chimeric human calcitonin and glucagons receptors reveal two dissociable calcitonin interaction sites. Biochemistry 34:1050-1057.
74. 2+/inositol phosphate signaling pathways. Mol Endocrinol 6:551-556.
75. 2+ mobilization and cell retraction. J Endocrinol 136:7-15.
76. 37). Biochem Biophys Res Commun 179:134-139.
77. Alam ASMT, Gallagher A, Shankar VS, Ghatei MA, Datta HK, Huang CL-H, Moonga BS, Chambers TJ, Bloom SR, Zaidi M 1992 Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: Implications for the vascular control of bone resorption. Endocrinology 130:3617-3624.
78. Alam ASMT, Moonga BS, Bevis PJR, Huang CL-H, Zaidi M 1993b Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 78:183-196.
79. Derst C, Engel H, Grzeschik K, Daut J 2000 Genomic structure and chromosome mapping of human and mouse RAMP genes. Cytogenet. Cell Genet. 90:115-118.
80. Leuthauser K, Gujer R, Aldecoa A, McKinney RA, Muff R, Fisher JA, Born W 2000 Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition. Biochem J 2:347-351.
81. Armour SL, Foord S, Kenakin T, Chen W 1999 Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. J Pharmacol Toxicol Meth 42:217-224.
82. Offermanns S, Iida-Klein A, Segre GV, Simon MI 1996 G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS cells. Mol. Endocrinol 10:566-574.
83. Shyu JF, Zhang Z, Hernandez-Lagunas L, Camerino C, Chen Y, Inoue D, Baron R, Horne WC 1999 Protein kinase C antagonizes pertussis toxin-sensitive coupling of the calcitonin receptor to adenylyl cyclase. Eur J Biochem 262:95-101.
84. Chen Y, Shyu JF, Santhanagopal A, Inoue D, David JP, Dixon SJ, Horne WC, Baron R 1998 The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C and calcium. J Biol Chem 273:19809-19816.
85. Naro F, Perez M, Migliaccio S, Galson DL, Orcell P, Teti A, Goldring SR 1998 Phospholipase D and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor. Endocrinology 139:3241-3248.
86. Duong LT, Lakkakorpi P, Nakamura I, Rodan GA 2000 Integrins and signaling in osteoclast function. Matrix Biol 19:97-105.
87. Zhang Z, Hernandez-Lagunas L, Horne WC, Baron R 1999 Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin and focal adhesion kinase. J Biol Chem 274:25093-25098.
88. Zhang Z, Baron R, Horne WC 2000 Integrin engagement, the actin cytoskeleton, and c-Src are required for the calcitonin-induced tyrosine phosphorylation of paxillin and HEF-1, but not for calcitonin-induced Erk1/2 phosphorylation. J Biol Chem 275:37219-37223.
89. Azria M, Copp DH, Zanelli JM 1995 25 years of salmon calcitonin: from synthesis to therapeutic use. Calcif Tissue Int 57:405-408.
90. Gruber HE, Ivey IL, Baylink DJ, Mathews M, Nelp WB, Sisom K, Chestnut CH 3rd 1984 Long term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295-303.
91. Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonnelli S, Francini G 1986 Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 38:3-8.
92. Reginster JY 1993 Calcitonin for prevention and treatment of osteoporosis. Am J Med 95 (Suppl 5A):44S-47S.
93. Overgaard K, Lindsay R, Christiansen C 1995 Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study. Clin Ther 17:680-685.
94. Zaidi M, Alam ASMT, Shankar VS, Fairburn K, Moonga BS, Huang CL-H, Panetta J, Blake DR, Pazianas M 1992 Inhibitors of bone resorption and implications for therapy. Curr Opin Ther Patents 2:1517-1538.
95. McDermott MT, Kidd GS 1987 The role of calcitonin in the development and treatment of osteoporosis. Endocr Rev 8:377-390.
96. Rico H, Hernandez ER, Revilla M, Gomez-Castresana F 1992 Salmon calcitonin reduces vertebral fracture rate in post-menopausal crush fracture syndrome. J Bone Miner Res 16:131-138.
97. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, Basle MF, Audran M 2000 Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res 15:13-19.
98. Dempster DW 2000 The contribution of trabecular architecture to cancellous bone quality. J Bone Miner Res 15:20-23.
99. MacIntyre I, Zaidi M 1990 Calcitonin: Some recent developments. In: DeLuca HF, Mazess, R (eds) Osteoporosis: Physiological Basis, Assessment, and Treatment. Elsevier, New York, pp. 233-240.
100. Lee YH, Sinko PJ 2000 Oral delivery of salmon calcitonin. Adv Drug Deliv Rev 42:225-231.
101. Chen G, Jayawickreme C, Way J, Armour S, Queen K, Watson C, Ignar D, Chen W, Kenakin T 1999 Constitutive receptor systems for drug discovery. J Pharmacol Toxicol Meth 42:199-206.
102. Lee YH, Perry BA, Sutyak JP, Stern W, Sinko PJ 2000 Regional differences in intestinal spreading and pH recovery and impact on salmon calcitonin absorption in dogs. Pharm Res 17:284-290.
103. Dogru ST, Calis S, Oner F 2000 Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro and in vivo evaluation. J Clin Pharm Ther 25:435-443.
104. Tozaki H, Nishioka J, Komoike J, Okada N, Fujita T, Muranishi S. Kim S.I. Terashima H. Yamamoto A 2001 Enhanced absorption of insulin and asu(1-7) eel calcitonin using novel azopolymer-coated pellets for colon-specific delivery. J Pharm Sci 90:89-97.
105. Chang SL, Hoffman G, Deftos LJ, Banga AK 2000 Transdermal iontophoretic delivery of salmon calcitonin. Int J Pharm 25:10-13.
106. Patton JS 2000 Pulmonary delivery of drugs for bone disorders. Adv Drug Deliv Rev 42:239-245.
107. Yoo SD, Jun H, Shin BS, Lee HS, Park MO, Deluca PP, Lee KC 2000 Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rat. Chem Pharm Bull 48:1921-1924.
108. Messina M, Yu DM, Learoyd DL, Both GW, Molloy PL, Robinson BG 2000 High level, tissue-specific expression of a modified calcitonin/calcitonin gene-related peptide promoter in a human medullary thyroid carcinoma cell line. Mol Cell Endocrinol 164:219-224.